IL6 and plasma cell myeloma: There is increasing evidence that the Interleukin-6 (IL-6) signaling pathway can be inhibited by metformin; specifically, metformin substantially reduces the expression of IL-6 receptors and promotes myeloma cell apoptosis in patients with primary myeloma (43).